An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer

Introduction: Multikinase inhibitors have clinical activity in radioactive iodine refractory (RAIR) differentiated thyroid cancers (DTCs) but are not curative; optimal management and salvage therapies remain unclear. This study assessed clinical effects of pazopanib therapy in RAIR-DTC patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thyroid
Main Authors: Bible, Keith C., Menefee, Michael E., Lin, Chia-Chi (Josh), Millward, Michael J., Maples, William J., Goh, Boon Cher, Karlin, Nina J., Kane, Madeleine A., Adkins, Douglas R., Molina, Julian R., Donehower, Ross C., Lim, Wan-Teck, Flynn, Patrick J., Richardson, Ronald L., Traynor, Anne M., Rubin, Joseph, LoRusso, Patricia M., Smallridge, Robert C., Burton, Jill K., Suman, Vera J., Kumar, Aditi, Voss, Jessie S., Rumilla, Kandalaria M., Kipp, Benjamin R., Chintakuntlawar, Ashish V., Harris, Pamela, Erlichman, Charles
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc., publishers 2020
Assuntos:
Thyroid Cancer and Nodules
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7482116/
https://ncbi.nlm.nih.gov/pubmed/32538690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2019.0269
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados